(Heteroarylmethyl) Thiohydantoins as anticancer drugs
    9.
    发明申请
    (Heteroarylmethyl) Thiohydantoins as anticancer drugs 审中-公开
    (杂芳基甲基)硫代乙内酰脲作为抗癌药物

    公开(公告)号:US20120238533A1

    公开(公告)日:2012-09-20

    申请号:US13395087

    申请日:2010-09-03

    CPC分类号: A61K31/275 A61K31/4439

    摘要: The invention refers to the use of androgen receptor antagonists for the treatment and/or prevention of fibroids, also known as uterine leiomyoma, leiomyomata. Particularly, the invention refers to the use of an androgen receptor antagonist being any one of the compounds according to the following list: cyproterone acetate, oxendolone, chlormadinone acetate, spironolactone, osaterone acetate, dienogest, flutamide, hydroxyflutamide, nilutamide, bicalutamide, RU 58841, LGD-2226, MDV3100, BMS-641988, BMS-779333, or 4-(3-{[6-(2-hydroxy-2-methylpropoxy)pyridin-3-yl]methyl}-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile (thioxoimidazolidine derivative) for the treatment of fibroids.

    摘要翻译: 本发明涉及雄激素受体拮抗剂用于治疗和/或预防子宫肌瘤,也称为子宫平滑肌瘤,平滑肌瘤的用途。 特别地,本发明涉及使用根据以下列举的化合物中的任何一种的雄激素受体拮抗剂:醋酸环丙孕酮,羟考灵,乙酸氯地孕酮,螺内酯,醋酸奥托酮,依诺孕,氟他胺,羟基氟他胺,尼鲁替胺,比卡鲁胺,RU 58841 ,LGD-2226,MDV3100,BMS-641988,BMS-779333或4-(3 - {[6-(2-羟基-2-甲基丙氧基)吡啶-3-基]甲基} -4,4-二甲基-5 - 氧代-2-硫代咪唑烷-1-基)-2-(三氟甲基)苄腈(硫代咪唑烷衍生物)。